NovaBay Pharmaceuticals, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US66987P3001
USD
1.22
0.03 (2.52%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
2.46
0.52
0.00
0.00
2.31
0.00
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2.46
0.52
0.00
0.00
2.31
0.00
0.00
Raw Material Cost
0.00
0.48
0.04
0.06
0.81
0.09
0.09
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.08
0.06
0.00
0.03
0.16
0.31
Selling and Distribution Expenses
2.85
1.21
1.85
2.65
2.78
1.62
1.52
Other Expenses
-0.00
-0.01
-0.01
0.00
-0.00
-0.02
-0.03
Total Expenditure (Excl Depreciation)
2.85
1.69
1.89
2.70
3.60
1.70
1.62
Operating Profit (PBDIT) excl Other Income
-0.4
-1.2
-1.9
-2.7
-1.3
-1.7000000000000002
-1.6
Other Income
-1.42
0.00
-0.02
-0.04
-0.07
0.02
-0.06
Operating Profit (PBDIT)
-1.80
-1.14
-1.87
-2.69
-1.26
-1.60
-1.58
Interest
0.00
0.08
0.06
0.00
0.03
0.16
0.31
Exceptional Items
557.66
-0.09
0.00
-0.59
0.07
-0.01
-0.16
Gross Profit (PBDT)
0.00
0.04
-0.04
-0.06
1.50
-0.09
-0.09
Depreciation
0.00
0.03
0.04
0.06
0.10
0.09
0.09
Profit Before Tax
555.86
-1.33
-1.96
-3.33
-1.32
-1.85
-2.15
Tax
3.45
0.00
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
552.40
-1.33
-1.96
-3.33
-1.32
-1.85
-2.15
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
552.40
-1.33
-1.96
-3.33
-1.32
-1.85
-2.15
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
552.40
-1.33
-1.96
-3.33
-1.32
-1.85
-2.15
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
138.82
-2.68
4.24
6.16
-0.14
1.07
-0.62
Earnings per share (EPS)
3.33
-1.1
-1.65
-3.33
-1.35
-9.6
-6.86
Diluted Earnings per share
3.33
-1.1
-1.65
-3.33
-1.35
-9.6
-6.86
Operating Profit Margin (Excl OI)
-15.63%
-224.38%
0.0%
0.0%
-55.83%
0.0%
0.0%
Gross Profit Margin
22568.29%
-249.33%
0.0%
0.0%
-53.18%
0.0%
0.0%
PAT Margin
22428.06%
-255.85%
0.0%
0.0%
-57.3%
0.0%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is 400.00% vs 0.00% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 42,592.31% vs 35.00% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 63.64% vs 42.11% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is -100.00% vs 0.00% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Sep 2025

Compare Quarterly Results Of NovaBay Pharmaceuticals, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
2.46
0.03
2.43
8,100.00%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2.46
0.03
2.43
8,100.00%
Raw Material Cost
0.00
-0.03
0.03
100.00%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0.23
-0.23
-100.00%
Selling and Distribution Expenses
2.85
1.44
1.41
97.92%
Other Expenses
-0.00
0.11
-0.11
-100.00%
Total Expenditure (Excl Depreciation)
2.85
2.71
0.14
5.17%
Operating Profit (PBDIT) excl Other Income
-0.38
-2.69
2.31
85.87%
Other Income
-1.42
0.17
-1.59
-935.29%
Operating Profit (PBDIT)
-1.80
-2.55
0.75
29.41%
Interest
0.00
0.23
-0.23
-100.00%
Exceptional Items
557.66
0.00
557.66
Gross Profit (PBDT)
0.00
0.05
-0.05
-100.00%
Depreciation
0.00
-0.03
0.03
100.00%
Profit Before Tax
555.86
-2.75
558.61
20,313.09%
Tax
3.45
0.00
3.45
Provisions and contingencies
0
0
0.00
Profit After Tax
552.40
-2.75
555.15
20,187.27%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
552.40
-2.75
555.15
20,187.27%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
552.40
-2.75
555.15
20,187.27%
Equity Capital
0
0
0.00
Face Value
0.01
0.00
0.00
Reserves
138.82
6.92
131.90
1,906.07%
Earnings per share (EPS)
3.33
-0.17
3.50
2,058.82%
Diluted Earnings per share
3.33
-0.17
3.50
2,058.82%
Operating Profit Margin (Excl OI)
-15.63%
-10,752.00%
0.00
10,736.37%
Gross Profit Margin
22,568.29%
-11,104.00%
0.00
33,672.29%
PAT Margin
22,428.06%
-11,000.00%
0.00
33,428.06%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 0.25 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 400.00% vs 0.00% in Sep 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 0.00% vs -100.00% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 55.24 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 42,592.31% vs 35.00% in Sep 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 16,839.39% vs -6.45% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -0.04 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 63.64% vs 42.11% in Sep 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 84.62% vs -62.50% in Mar 2025

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -15.63%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025